4 - 4 |
Live from Pittcon [Anonymous] |
5 - 5 |
Dual therapy first weakens, then kills antibiotic-resistant pathogens The drug pentamidine disrupts the outer membrane of Gram-negative bacteria, allowing antibiotics inside to finish the job Everts S |
6 - 6 |
Quantum effect could explain chiral interactions Electron spin polarization dictates recognition between chiral compounds Kemsley J |
6 - 6 |
George Olah dies at 89 Nobel Laureate advanced carbocation chemistry and alternative-energy technology Jacoby M |
7 - 7 |
Data bit stored on single atom Lab demo may lead to strategies for boosting data-storage density Jacoby M |
8 - 8 |
Enzyme-inspired route to heterocycle functionalization Bifunctional metal agents reversibly coordinate heterocycles and derivatize them at remote sites Borman S |
9 - 9 |
Refining a crude analysis Method improves crude oil separation, could aid petrochemical refining and spill assessment Peplow M |
10 - 10 |
Nonlinear optical laser material avoids beryllium Wilson E |
10 - 10 |
Sweetener tracks tinkling in the pool Arnaud C |
10 - 11 |
Indole alkaloid biosynthetic pathways unraveled Borman S |
11 - 11 |
Nanostructures lift the fog Davenport M |
11 - 11 |
Bumblebees leave foot odor on flowers Everts S |
11 - 11 |
Nitrogen Lewis acids unveild Ritter S |
12 - 12 |
Rejecting PPG bid, AkzoNobel will exit chemicals Proposed merger would be latest consolidation move for industry Mccoy M |
12 - 12 |
Nestle, Danone look to renewable bottles Tullo A |
13 - 13 |
DSM, Evonik form omega-3 joint venture Scott A |
13 - 13 |
Instrument makers invest in cloud computing Reisch M |
13 - 13 |
Vertex buys Concert's cystic fibrosis drug Thayer A |
14 - 15 |
Perstorp sells Belgium site to Synthomer Scott A |
14 - 14 |
BASF, others back P2 Science Mccoy M |
14 - 14 |
Alberta funds CO2 to chemicals Mccoy M |
14 - 14 |
Fine Industries sold to Chinese buyer Scott A |
14 - 14 |
Sumitomo to triple OLED touch screens Tremblay JF |
14 - 14 |
FDA warns Wockhardt, Fosun Tremblay JF |
14 - 14 |
Biobased startup tries new financing route Tullo A |
15 - 15 |
Sanofi, AstraZeneca in respiratory deal Mullin R |
15 - 15 |
Boehringer, Vanderbilt pact targets KRAS Mullin R |
15 - 15 |
Otsuka to acquire Neurovance Thayer A |
15 - 15 |
China's BeiGene plans biologics plant Tremblay JF |
15 - 15 |
Wacker will expand silicon in Norway Tullo A |
15 - 15 |
Business Roundup [Anonymous] |
16 - 16 |
Selections from cen.chempics.org, where C&EN showcases the beauty of chemistry Morone M |
16 - 16 |
EPA scraps methane reporting for oil and gas industries Pruitt kills data collection at several states' request Johnson J |
17 - 17 |
US said to be falling behind in advanced reactors Morrison J |
17 - 17 |
Prepare for flood of new products, report says Morrison J |
17 - 17 |
Chemical sector outlines priorities for NAFTA rewrite Hess G |
17 - 17 |
US, EU to share pharma inspection reports Erickson B |
20 - 21 |
Foreign students and postdocs in US worry about the future While Trump takes aim at immigration, foreign trainees consider taking their talents elsewhere Wang L |
23 - 25 |
Electrosynthesis gives chemists more power Organic chemists find using electric current as a reagent helps streamline reactions Ritter SK |
26 - 27 |
Chemical firms exit 2016 with some bruises Demand was strong for some specialties, but results showed the impact of slow growth and lower prices Bomgardner MM |
28 - 29 |
Pharmaceutical firms saw modest growth in 2016 Individual company results were mixed as sales of major products were beset by patent squabbles and expirations Thayer AM |
30 - 31 |
Spider venom: An insecticide whose time has come? Bioinsecticide maker Vestaron says fruit and vegetable farmers are ready for its spider venom peptide Bomgardner MM |
34 - 35 |
C&EN talks with Fraser Stoddart, 2016 chemistry laureate Northwestern professor discusses his legacy and hopes for scientists in China Tremblay JF |
37 - 38 |
Clovis takes Lonza up on a dedicated plant for its cancer drug The Swiss fine chemicals firm applies a biologics strategy to small-molecule manufacturing Mullin R |
42 - 43 |
Immunomedics and Johnson Matthey connect for ADCs Special handling delivers drug and linker combo for creating tumor-targeting antibody-drug conjugate Thayer AM |
44 - 45 |
AMRI can do Nemus's cannabinoid chemistry Mccoy M |
47 - 47 |
Introducing fast and easy options to update bylaws Carver JC |
80 - 80 |
The ketchup problem Torrice M |